GlassScriptPhysician profile
Marcus J Neitzke
NPI 1548262033
$13,516.83
in general payments reported to CMS, 2019-2025
14 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,314 · 2020: $707 · 2021: $1,662 · 2022: $1,034 · 2023: $3,070 · 2024: $1,852 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,796 · Travel and Lodging: $1,918 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Entertainment: $85.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,796.39 |
| Travel and Lodging | $1,917.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Entertainment | $85.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,629.00 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $3,319.90 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,854.67 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $1,397.90 | 2022-2025 | Infuse, Miebo, Xiidra |
| Lkc Technologies, INC. | $446.24 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $148.31 | 2024 | Xdemvy |
| Allergan, INC. | $145.88 | 2021-2022 | |
| Horizon Therapeutics Plc | $137.68 | 2022 | |
| Glaukos Corporation | $117.79 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $111.95 | 2021 | |
| Optos, INC. | $85.26 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Topcon Healthcare, INC. | $77.73 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.44 | 2022 | |
| Abbvie INC. | $21.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Neitzke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.